Bright Minds Biosciences Inc. DRUG
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 475.31% | 472.73% | 61.40% | 1,305.79% | 733.05% |
| Total Receivables | 288.19% | 402.52% | 686.70% | 697.31% | 1,486.51% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 83.46% | 274.72% | 403.23% | 342.21% | 1,119.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 469.04% | 471.03% | 63.64% | 1,265.81% | 738.72% |
|
|
|||||
| Total Current Assets | 469.04% | 471.03% | 63.64% | 1,265.81% | 738.72% |
| Net Property, Plant & Equipment | -60.57% | -51.72% | -45.37% | -7.69% | 975.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 467.73% | 469.60% | 63.31% | 1,241.29% | 739.17% |
|
|
|||||
| Total Accounts Payable | 344.59% | 578.10% | 302.00% | 306.99% | 242.63% |
| Total Accrued Expenses | 584.62% | 1,271.43% | 333.02% | 1,155.99% | 6.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.37% | 8.69% | 27.33% | 3.23% | 461.76% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 303.81% | 518.70% | 259.79% | 328.47% | 239.92% |
|
|
|||||
| Total Current Liabilities | 303.81% | 518.70% | 259.79% | 328.47% | 239.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -84.05% | 1.02% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 265.80% | 442.97% | 193.58% | 305.66% | 275.25% |
|
|
|||||
| Common Stock & APIC | 290.93% | 318.99% | 61.23% | 237.46% | 157.44% |
| Retained Earnings | -51.43% | -78.59% | -65.65% | -31.52% | -27.00% |
| Treasury Stock & Other | 91.89% | 144.58% | 124.69% | 16.80% | -4.32% |
| Total Common Equity | 470.34% | 469.95% | 62.02% | 1,337.32% | 752.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 470.34% | 469.95% | 62.02% | 1,337.32% | 752.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 470.34% | 469.95% | 62.02% | 1,337.32% | 752.76% |
|
|
|||||